Font Size:
a
A
A
Keyword [hepatitis B cirrhosis]
Result: 181 - 200 | Page: 10 of 10
181.
Assessment Of Renal Imaging Changes In Patients With Hepatitis B Cirrhosis By ARFI-VTQ And CDFI
182.
The Relationship Between Neutrophil Lymphocyte Ratio(NLR),red Blood Cell Volume Distribution Width(RDW),and Hepatitis B And Liver Cirrhosis
183.
Clinical Significance Of Serum Protoporphyrin ? Determination In Patients With Hepatitis B Cirrhosis
184.
Analysis Of Clinical Characteristics And Risk Factors Of 169 Patients With Hepatitis B Cirrhosis And Kidney Injury
185.
Distribution Of Traditional Chinese Medicine Syndromes Of Hepatitis B Cirrhosis Ascites (Bulge)and Its Correlation
186.
Distribution Pattern Of TCM Syndromes Of Hepatitis B Cirrhosis(Compensation Period)and Related Research
187.
Research Of The Nomogram To Predict The Risk Of Hepatitis B Cirrhosis Patients After Splenectomy Developing Into PVST
188.
Analysis Of Risk Factors Of Acute Renal Injury In Patients With Decompensated Hepatitis B Cirrhosis
189.
Type 2 Diabetes Is Associated With Increased Risk For Cirrhosis In Chronic Hepatitis B Patients Without Antiviral Therapy
190.
Study On Intestinal Barrier Function And Microecology Of Patients With Hepatitis B Virus Cirrhosis
191.
Clinical Study Of Entecavir Combined With Glucobay On Insulin Resistance In Patients With Hepatitis B Cirrhosis Complicated With Hepatogenic Diabetes
192.
Study On The Effect Of Drug Zero-Profit Policy On The Cost Burden And Diagnosis And Treatment Of Patients With Chronic Hepatitis B Related Diseases
193.
The Predictive Value Of FibroScan And GPRI In The Degree Of Esophageal Varices In Patients With Hepatitis B Cirrhosis
194.
Changes Of Coagulation,Anticoagulation And Fibrinolysis System In Patients With Different Child-Pugh Grade Cirrhosis
195.
Effects Of Integrated Treatment Of Traditional Chinese Medicine And Western Medicine On The Incidence Of Hepatocellular Carcinoma After Liver Cirrhosis With Hepatitis B
196.
The Effect Of Collaboration Care For Adherence Behavior To Medical Treatments Of Rural Patients With Hepatitis B Cirrhosis
197.
Correlation Between PNPLA3 And IFNLR1 Gene Polymorphisms And Response To Antiviral Therapy In Patients With Hepatitis B Cirrhosis
198.
Based On The "Liver-gut Axis" Study Of Rougan Huaxian Granules To Regulate Intestinal Flora Imbalance And Treatment Of Compensated Hepatitis B Cirrhosis
199.
Clinical Observation Of The Therapeutic Effect Of Rougan Huaxian Granule Combined With Entecavir In The Treatment Of Hepatitis B Cirrhosis(Syndrome Of Liver-kidney Yin Deficiency)
200.
Clinical Observation Of Zhuanggan Zhuyu Decoction Combined With Entecavir In The Treatment Of Decompensated Period Of Hepatic Cirrhosis With Deficiency And Stasis Type B
<<First
<Prev
Next>
Last>>
Jump to